You are here

  • Home
  • Archive
  • Volume 20, Issue 6
  • Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products

Article Text

Article menu
Download PDFPDF
Research letter
Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products

http://dx.doi.org/10.1136/tc.2010.037648

Statistics from Altmetric.com

    Footnotes

    • Funding Our research on smokeless tobacco is supported by grants CA-81301, CA-141531, CA-1135884, and DA-013333 from the US National Institutes of Health.

    • Competing interests SSH is a witness for the plaintiff in a smokeless tobacco case. DKH has a grant from Nabi Biopharmaceuticals to conduct a clinical trial for the nicotine vaccine.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.